UNSPSC 85882017: Tomographic (tomo) nuclear medicine imaging of head and neck using thallium 201 (tl-201)

This classification denotes the group of activities that yields an intervention or procedure of tomographic (tomo) nuclear medicine imaging of head and neck using thallium 201 (tl-201). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CW2BSZZ

UNSPSC 85882017 Tomographic (tomo) nuclear medicine imaging of head and neck using thallium 201 (tl-201) is a Commodity code with little alignment to recent state and local procurement activity. The three most recent opportunities tagged to this code—a diagnostic imaging Picture Archiving and Communication System (PACS) implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District in Texas, and temporary health professional staffing across multiple clinical categories at the County of Santa Clara Health System—do not involve tomographic nuclear medicine imaging using thallium 201. The PACS solicitation centers on enterprise radiology, cardiology, and dental imaging system infrastructure and data migration; the special education services cover speech therapy, occupational therapy, physical therapy, and related support roles; and the health professional staffing vehicle covers audiology, cardiology services, diagnostic imaging/radiology, and therapy roles in temporary staffing capacity. None of these opportunities directly procure the diagnostic imaging modality or radiopharmaceutical specified in the code's name.

The source provides no concrete evidence of state and local procurement demand for tomographic nuclear medicine imaging services using thallium 201 as a standalone service line or product. Discontinue active pursuit of this code until market research surfaces relevant opportunities with issuing bodies such as hospital systems, county health departments, or regional medical centers that explicitly solicit nuclear medicine imaging services or radiopharmaceuticals in that category.